Cynosure Lutronic's XERF monopolar RF platform is gaining rapid adoption across North American medspa and surgical practices, emerging as a credible alternative to InMode's Morpheus8 in the RF microneedling category. Monopolar RF delivers energy deeper into the dermis and subcutis than fractional microneedling RF, making it suitable for skin tightening, collagen remodeling, and larger-area treatments.
The XERF's market traction reflects both competitive pricing and clinical efficacy. Morpheus8 has dominated the fractional RF-microneedling segment since its launch, but monopolar RF offers a different clinical profile—broader energy distribution, fewer passes required, and potentially faster treatment times. Practices seeking to diversify their RF portfolio or reduce per-treatment cost-of-goods may view XERF as a complementary or alternative investment.